Chang-il Hwang (right), an associate professor of microbiology and molecular genetics, and Suyakarn (Sonia) Archasappawat, a graduate student in his lab, study why cancers become resistant to a promising class of anti-tumor drugs. Their new research reveals how cancer cells evade BET inhibitors, pointing to a potential combination therapy that could help prevent drug resistance across multiple cancer types. Credit:…